Loading data
DCOYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 0 USD | 1.84 m USD |
| Research and development expense | 368.17 k USD | 770.03 k USD | 7.17 m USD | 15.84 m USD | 8.55 m USD |
| Operating profit | -12.61 m USD | -5.73 m USD | -12.89 m USD | -31.84 m USD | -12.81 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | 12.52 m USD | 5.58 m USD | 12.54 m USD | 31.61 m USD | -12.77 m USD |
| Net income attributable to common shareholders | — | -5.58 m USD | -12.54 m USD | -31.61 m USD | -12.77 m USD |
| Basic earnings per share | -129.1 USD/share | -69.54 USD/share | -30.74 USD/share | -119.02 USD/share | -7.72 USD/share |
| Diluted earnings per share | -129.1 USD/share | -69.54 USD/share | -30.74 USD/share | -119.02 USD/share | -7.72 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.